ANAB Valuation

AnaptysBio Inc

Add to Watchlist

Advanced Chart

21.190

-0.510(-2.350%)

Overview
Forecast
Valuation

ANAB Relative Valuation

ANAB's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ANAB is overvalued; if below, it's undervalued.

Historical Valuation

AnaptysBio Inc (ANAB) is now in the Fair zone, suggesting that its current forward PS ratio of 14.05 is considered Fairly compared with the five-year average of 29.75. The fair price of AnaptysBio Inc (ANAB) is between 8.40 to 68.00 according to relative valuation methord.

Relative Value

Fair Zone

8.40-68.00

Current Price：21.19

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

9.33

P/B

Median3y

14.94

Median5y

9.66

-19.91

FCF Yield

Median3y

-16.02

Median5y

-11.85

Competitors Valuation Multiple

The average P/S ratio for ANAB's competitors is 6.64, providing a benchmark for relative valuation. AnaptysBio Inc Corp (ANAB) exhibits a P/S ratio of 14.05, which is 111.46% above the industry average. Given its robust revenue growth of 378.77%, this premium appears sustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap